Cassation No. 206 of 2022
Issued on 05/04/2022 (Penal)
Panel: Presided over by Mr. Judge Ahmed Abdullah Al-Mulla, “Chief Judge of the Circuit”, with Messrs. Judges Muhammad Ahmed Abdel Qader and Al-Tayeb Abdel Ghafour Abdel Wahhab as members.
1- The respondent stands classified as a recidivist since it is established that he committed a crime involving the abuse of the psychotropic substance amphetamine, received a prior punishment under a final ruling, and subsequently repeated the same offence within a period not exceeding three years. This necessitates imposing his punishment in accordance with Article 41/2 of Law No. 30 of 2021
(1, 2) Narcotics and psychotropic substances “Possession of narcotics and psychotropic substances with the intent to abuse: Case of recidivism.” Ruling “Deficiencies in reasoning: Error in the Application of the Law.”
(1) It is stipulated that an offender who returns to abusing narcotics or psychotropic substances, consuming a dose above that specified in the medical prescription and outlined in Tables No. 1, 2, and 5, except for Item 29 of Table No. 1, within a period not exceeding three years from the initial act, shall face imprisonment for a minimum term of six months as per Article 41/2 of Law 30 of 2021.
(2) The respondent's commission of the crime of consuming narcotics, receiving a final ruling, and subsequently repeating the same act within a period not exceeding three years qualifies as recidivism. Condition therefor. Its effect. The necessity of applying Article 41/2 of Law 30 of 2021. The contested ruling has violated this regulation, displaying an error in the application of the law.
1- It is established according to Article 41 of Federal Decree Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances, effective from 2/1/2022, that:
“1- A penalty of imprisonment for a term not less than three months or a fine between twenty thousand dirhams and one hundred thousand dirhams shall be imposed on anyone who:
a- abuses or personally uses, in unauthorised circumstances or in doses greater than those specified in the medical prescription, any narcotics or psychotropic substances as detailed in Tables No. (1), (2), and (5), excluding item (29) in Table No. (1)....
2- If the offender repeats any of the acts stipulated in the preceding clause within a period not exceeding three years from the initial offense, the penalty shall be imprisonment for a duration not less than six months...”
2- In the present circumstances, and whereas it has been substantiated in the documentation that the respondent previously committed a narcotics-abuse crime prior to 3/6/2019, leading to a two-year imprisonment ruling issued by the first-instance court in Penal Case No. 383 of 2019 in the session held on 11/12/2019, and confirmed by Appeal No. 532 of 2019 on 31/12/2019. Additionally, on 16/10/2021, the respondent again abused the psychotropic substance (amphetamine), subject-matter of the appeal. Consequently, this repetition of the offence within the three-year timeframe qualifies the respondent as a recidivist. Notably, there is no evidence to support rehabilitation or the prescription of the penalty by the statute of limitations according to Article 315/3 of the Criminal Procedure Law. Furthermore, no comprehensive pardon has been granted to the respondent, and Law No. 30 of 2021 has neither abolished nor authorised the criminalisation concerning the previously charged act. Thus, the criminal implications persist. Consequently, he shall be punished in accordance with Article 41/2 of the aforementioned law. Given the contested ruling sentenced the appellant to three months' imprisonment, it is considered as having erred in the application of the law, which requires its reversal as to the part related to the punishment imposed on the respondent.
The court,
Whereas in the facts, as apparent pursuant to the perusal of the contested ruling and the remaining documents, the Public Prosecution accused the respondent of having on 16/10/2021 in the Department of ......... City:-
Abused as a recidivist, psychotropic substances (methamphetamine) in circumstances other than those permitted by law, as indicated in the investigations.
The Public Prosecution sought the respondent's penalization in accordance with Articles 1, 6, 34, 39, and 65 of Federal Law No. 14 of 1995 on Combatting Narcotics and Psychotropic Substances, as amended, in conjunction with Item No. 9 of Table 5 appended to said law.
Subsequently, on 15/11/2021, the court of first instance rendered a judgment imposing a two-year imprisonment sentence upon ..... for the charges, alongside the mandate to settle judicial fees.
The convict contested this ruling by filing an appeal.
Later, in a session held on 14/2/2022, in Appeal No. 383 of 2021, the Federal Court of Appeal accepted the appeal in form and, on the merits, altered modified the appealed ruling into stipulating a three-month imprisonment term for the aforementioned charge against the accused, while also requiring payment of fees.
The Public Prosecution, in disagreement with the prior judgment, filed the current appeal in cassation.
Whereas, the basis for the Prosecution's objection to the contested ruling lies in its alleged error in the application of the law, specifically in mitigating the penalty below the minimum prescribed by the second paragraph of Article 42 of Decree Law No. 30 of 2021 on Combatting Narcotics and Psychotropic Substances. This objection is rooted in the respondent's prior commission of a similar offence and subsequent punishment on 31/12/2019. Considering that the act of drug abuse in the present case transpired over a span of three years, the Prosecution contends that the court should have imposed a minimum sentence of six months' imprisonment. The contested ruling, by reducing the penalty to the minimum, is deemed flawed and necessitates reversal.
Whereas the objection of the public prosecution holds merits, since It is established according to Article 41 of Federal Decree Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances, effective from 2/1/2022, that:
“1- A penalty of imprisonment for a term not less than three months or a fine between twenty thousand dirhams and one hundred thousand dirhams shall be imposed on anyone who:
a- abuses or personally uses, in unauthorised circumstances or in doses greater than those specified in the medical prescription, any narcotics or psychotropic substances as detailed in Tables No. (1), (2), and (5), excluding item (29) in Table No. (1)....
2- If the offender repeats any of the acts stipulated in the preceding clause within a period not exceeding three years from the initial offense, the penalty shall be imprisonment for a duration not less than six months...”
2- In the present circumstances, and whereas it has been substantiated in the documentation that the respondent previously committed a narcotics-abuse crime prior to 3/6/2019, leading to a two-year imprisonment ruling issued by the first-instance court in Penal Case No. 383 of 2019 in the session held on 11/12/2019, and confirmed by Appeal No. 532 of 2019 on 31/12/2019. Additionally, on 16/10/2021, the respondent again abused the psychotropic substance (amphetamine), subject-matter of the appeal. Consequently, this repetition of the offence within the three-year timeframe qualifies the respondent as a recidivist. Notably, there is no evidence to support rehabilitation or the prescription of the penalty by the statute of limitations according to Article 315/3 of the Criminal Procedure Law. Furthermore, no comprehensive pardon has been granted to the respondent, and Law No. 30 of 2021 has neither abolished nor authorised the criminalisation concerning the previously charged act. Thus, the criminal implications persist. Consequently, he shall be punished in accordance with Article 41/2 of the aforementioned law. Given the contested ruling sentenced the appellant to three months' imprisonment, it is considered as having erred in the application of the law, which requires its reversal as to the part related to the punishment imposed on the respondent, with remand.

* * *